ALPS Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-93,978
| Closed | -$1.05M | – | 909 |
|
|
2017
Q3 | $1.05M | Sell |
93,978
-3,390
| -3% | -$38K | 0.01% | 237 |
|
|
2017
Q2 | $1.07M | Buy |
97,368
+2,542
| +3% | +$28K | 0.01% | 225 |
|
|
2017
Q1 | $929K | Buy |
94,826
+4,720
| +5% | +$46.2K | 0.01% | 224 |
|
|
2016
Q4 | $973K | Sell |
90,106
-14,211
| -14% | -$153K | 0.01% | 220 |
|
|
2016
Q3 | $1.07M | Sell |
104,317
-9,384
| -8% | -$96.2K | 0.01% | 220 |
|
|
2016
Q2 | $1.49M | Buy |
113,701
+11,379
| +11% | +$149K | 0.01% | 190 |
|
|
2016
Q1 | $1.13M | Buy |
102,322
+35,240
| +53% | +$388K | 0.01% | 183 |
|
|
2015
Q4 | $617K | Sell |
67,082
-10,555
| -14% | -$97.1K | 0.01% | 259 |
|
|
2015
Q3 | $5.39K | Buy |
77,637
+28,414
| +58% | +$1.97K | 0.01% | 279 |
|
|
2015
Q2 | $483K | Buy |
49,223
+24,027
| +95% | +$236K | ﹤0.01% | 546 |
|
|
2015
Q1 | $223K | Buy |
+25,196
| New | +$223K | ﹤0.01% | 641 |
|